CDA | Evidence Driven
CDA | Evidence Driven

Eltrombopag for the treatment of Aplastic Anemia: A Review of Clinical and Cost-Effectiveness

Details

Files
Project Line:
Health Technology Review
Project Sub Line:
Summary with Critical Appraisal
Project Number:
RC1001-000

Question

  1. What is the clinical effectiveness of eltrombopag in the treatment of aplastic anemia?
  2. What is the cost-effectiveness of eltrombopag in the treatment of aplastic anemia?

Key Message

There were no studies that met the pre-specified criteria regarding the comparative clinical effectiveness and cost-effectiveness of eltrombopag for the treatment of aplastic anemia.

Files

Eltrombopag for the treatment of Aplastic Anemia: A Review of Clinical and Cost-Effectiveness Rapid Response July 9, 2018 View PDF
Last Updated : July 9, 2018